Saringer Life Science Technologies Introduces Next Generation Mobile Compression Device and US Distribution Partner

Share Article

Saringer Life Science Technologies introduces Venowave 2 and announces their American partnership with DVT Lite.

Saringer Life Science Technologies, a medical device company headquartered in Toronto Canada, has announced a next-generation model of the Venowave mobile compression device- the Venowave2.

The first generation Venowave is the first and only mobile compression device to use patented peristaltic technology for continuous blood movement. The lightweight, compact design offers portability and increased patient compliance for use post-discharge for prevention of venous thromboembolism (VTE).

As the length of post-surgical hospital stays decrease, the need continues to rise for products that are able to provide true continuum of care applied in the hospital at surgery and after discharge into the patients’ home. This need has driven the improvements to the second generation Venowave2. With compliance meters, audible alarms and multi-patient reusable functionality, the Venowave2 can easily transition from use in the acute care setting into the patient’s home.

Clinicians are faced with weighing patients’ bleeding risks against the risk of post-surgical DVT/PE. The Venowave2 is among the proven solutions now available, which are able to offer prevention without increasing bleeding risks. The portability helps to increase comfort and wearability, which ultimately leads to better patient compliance.
The Venowave has been certified by health authorities including, the Federal Drug Administration (FDA) in the United States, CE Mark in Europe (stringent ISO 13485 standards for design and manufacturing) and Health Canada.

The Venowave was inspired by inventor and entrepreneur John Saringer who, working with Dr. Jack Hirsh, a professor of medicine at McMaster University, and associated teaching hospitals in Hamilton, Ontario—says their mechanical pumps such as Venowave have a natural superiority over compression stockings.

Saringer Life Science Technologies is pleased to have partnered with DVTlite, a company headquartered in Atlanta, GA for the United States distribution of the Venowave2. DVTlite specializes in mechanical prophylaxis for VTE prevention by providing innovative DVT prevention pumps to healthcare facilities, physicians and patients.

Share article on social media or email:

View article via:

Pdf Print